L. Tominna

Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic

J. Best, I. Abbass, S. Vlad, 2020, Rheumatology and Therapy.